Promoter methylation status and expression of O6-Methylguanine-DNA-Methyltransferase (MGMT) in pediatric brain germ cell tumors

Promoter methylation status and expression of O6-Methylguanine-DNA-Methyltransferase (MGMT) in pediatric brain germ cell tumors

碩士 === 國立陽明大學 === 生命科學暨基因體科學研究所 === 97 === Alkylating drugs such as temozolomide is used in the treatment of several human cancers, but the cytotoxicity of these anticancer drugs results from the alkylation of DNA is strongly attenuated by the repair ability of O6-methylguanine-DNA methyltransferase...

Full description

Bibliographic Details
Main Authors:	Chun-Hsiang Pai, 白竣翔
Other Authors:	Yann-Jang Chen
Format:	Others
Language:	en_US
Published:	2009
Online Access:	http://ndltd.ncl.edu.tw/handle/2p6h9w

Similar Items

O-methylguanine-DNA methyltransferase (MGMT) mRNA expression predicts outcome in malignant glioma independent of MGMT promoter methylation.
by: Simone Kreth, et al.
Published: (2011-02-01)

O6-methylguanine-DNA methyltransferase (MGMT) Promoter methylation is a rare event in soft tissue sarcoma
by: Jakob Jens, et al.
Published: (2012-10-01)

O6-Methylguanine-DNA Methyltransferase (MGMT): Challenges and New Opportunities in Glioma Chemotherapy
by: Wei Yu, et al.
Published: (2020-01-01)

Determining methylation status of methylguanine DNA methyl transferase (MGMT) from formalin-fixed, paraffin embedded tumor tissue
by: Francine B. de Abreu, et al.
Published: (2014-01-01)

Changes of O<sup>6</sup>-Methylguanine DNA Methyltransferase (MGMT) Promoter Methylation in Glioblastoma Relapse—A Meta-Analysis Type Literature Review
by: Jonas Feldheim, et al.
Published: (2019-11-01)

O6-Methylguanine-Methyltransferase (MGMT) Promoter Methylation Status in Glioma Stem-Like Cells is Correlated to Temozolomide Sensitivity Under Differentiation-Promoting Conditions
by: Lucie Karayan-Tapon, et al.
Published: (2012-06-01)

Rare Stochastic Expression of O6-Methylguanine- DNA Methyltransferase (MGMT) in MGMT-Negative Melanoma Cells Determines Immediate Emergence of Drug-Resistant Populations upon Treatment with Temozolomide In Vitro and In Vivo
by: Thomas C. Chen, et al.
Published: (2018-09-01)

Modulation of N-Methyl-N-nitrosourea Mutagenesis in Mouse Embryo Fibroblasts Derived from the gpt Delta Mouse by an Inhibitor of the O6-Methylguanine Methyltransferase, MGMT
by: Thongararm, Pennapa, et al.
Published: (2020)

The Clinical Significance of O6-Methylguanine-DNA Methyltransferase Promoter Methylation Status in Adult Patients With Glioblastoma: A Meta-analysis
by: Yu-Hang Zhao, et al.
Published: (2018-03-01)

S-phase Specific Downregulation of Human O6-Methylguanine DNA Methyltransferase (MGMT) and its Serendipitous Interactions with PCNA and p21cip1 Proteins in Glioma Cells
by: AGM Mostofa, et al.
Published: (2018-04-01)

A role for O⁶-methylguanine DNA methyltransferase in cellular function and carcinogenesis /
by: Dutta-Choudhury, Tapu Ashis
Published: (1989)

O-6-methylguanine-DNA methyltransferase promoter methylation can change in glioblastoma recurrence due to intratumor heterogeneity
by: Valeria Barresi, et al.
Published: (2018-01-01)

O6-Methylguanine-DNA-Methyltransferase methylation: prevalence and predictive value in head and neck squamous cell carcinoma
by: Abou Chacra, Zahi
Published: (2011)

O6-Methylguanine-DNA-Methyltransferase methylation: prevalence and predictive value in head and neck squamous cell carcinoma
by: Abou Chacra, Zahi
Published: (2011)

Temozolomide Induces the Acquisition of Invasive Phenotype by O6-Methylguanine-DNA Methyltransferase (MGMT)<sup>+</sup> Glioblastoma Cells in a Snail-1/Cx43-Dependent Manner
by: Paweł Kochanowski, et al.
Published: (2021-04-01)

O6-methylguanine-DNA Methyltransferase Promoter Methylation in Patients with Rectal Adenocarcinoma After Chemoradiotherapy Treatment: Clinical Implications
by: Jaime A. Oliver, et al.
Published: (2019-09-01)

Both base excision repair and O-6-methylguanine-DNA methyltransferase protect against methylation-induced colon carcinogenesis
by: Samson, Leona D., et al.
Published: (2011)

Drug discovery study of O6-methylguanine-DNA methyltransferase via virtual screening
by: Ssu-Shang Chang, et al.
Published: (2017)

A type I combi-targeting approach for the design of molecules with enhanced potency against BRCA1/2 mutant- and O6-methylguanine-DNA methyltransferase (mgmt)- expressing tumour cells
by: Zhor Senhaji Mouhri, et al.
Published: (2017-08-01)

Evaluation of O6-methylguanine-DNA methyltransferase enzyme expression effect on survival of patients with Grade 4 brain astrocytoma
by: Simin Hemati, et al.
Published: (2014-01-01)

Evaluation of prognostic utility of Ki-67, P53, and O-6-methylguanine-DNA methyltransferase expression in pituitary tumors
by: Chhanda Das, et al.
Published: (2019-10-01)

Homogeneous MGMT immunoreactivity correlates with an unmethylated MGMT promoter status in brain metastases of various solid tumors.
by: Barbara Ingold, et al.
Published: (2009-01-01)

O-6-methylguanine-deoxyribonucleic acid methyltransferase methylation enhances response to temozolomide treatment in esophageal cancer
by: Rifat Hasina, et al.
Published: (2013-01-01)

Transcriptional response of O⁶-methylguanine methyltransferase deficient yeast to methyl-N-nitro-N-nitrosoguanidine (MNNG)
by: Rao, Anoop, 1977-
Published: (2005)

Atomic Insight into the Altered O6-Methylguanine-DNA Methyltransferase Protein Architecture in Gastric Cancer.
by: Naveed Anjum Chikan, et al.
Published: (2015-01-01)

O<sup>6</sup>-methylguanine-DNA methyltransferase in equine sarcoids: molecular and epigenetic analysis
by: Altamura Gennaro, et al.
Published: (2012-11-01)

O6-methylguanine-DNA methyltransferase promoter methylation and isocitrate dehydrogenase mutation as prognostic factors in a cohort of Saudi patients with glioblastoma
by: Ali H. Alassiri, et al.
Published: (2019-12-01)

MiR-221/222 target the DNA methyltransferase MGMT in glioma cells.
by: Cristina Quintavalle, et al.
Published: (2013-01-01)

O6-Methylguanine-DNA methyltransferase protein expression by immunohistochemistry in brain and non-brain systemic tumours: systematic review and meta-analysis of correlation with methylation-specific polymerase chain reaction
by: Ibáñez Javier, et al.
Published: (2011-01-01)

Combination chemoradiotherapy with temozolomide, vincristine, and interferon-β might improve outcomes regardless of O6-methyl-guanine-DNA-methyltransferase (MGMT) promoter methylation status in newly glioblastoma
by: Kenichiro Asano, et al.
Published: (2021-07-01)

O 6-methylguanine DNA methyltransferase and glucose transporter 2 in foregut and hindgut gastrointestinal neuroendocrine neoplasms
by: Hirofumi Watanabe, et al.
Published: (2020-12-01)

Phenotypic selection through cell death: stochastic modelling of O-6-methylguanine-DNA methyltransferase dynamics
by: Ayoub Lasri, et al.
Published: (2020-07-01)

A multifaceted review of temozolomide resistance mechanisms in glioblastoma beyond O-6-methylguanine-DNA methyltransferase
by: Peter Y. M. Woo, et al.
Published: (2019-01-01)

Prognostic effects of O6-Methylguanine DNA methyltransferase promoter hypermethylation in high-grade glioma patients with carmustine wafer implants
by: Mao-Yu Chen, et al.
Published: (2017-01-01)

MGMT Methylation Status: The Advent of Stratified Therapy in Glioblastoma?
by: Peter Hau, et al.
Published: (2007-01-01)

Role of O6-methylguanine-DNA methyltransferase and p53 in response of neuroblastoma cells to an alkylating agent temozolomide
by: R R Khusnutdinov, et al.
Published: (2018-02-01)

High-dose radiotherapy in newly diagnosed low-grade gliomas with nonmethylated O(6)-methylguanine-DNA methyltransferase
by: Yanwei Liu, et al.
Published: (2021-08-01)

Preclinical evaluation of an O6-methylguanine-DNA methyltransferase-siRNA/liposome complex administered by convection-enhanced delivery to rat and porcine brains
by: 辻内, 高士, et al.
Published: (2014)

Investigation of the Mechanism Underlying the Ubiquitination of O6-Methylguanine-DNA Methyltransferase Induced by Alkylating Agents and Its Clinical Significance
by: Shih-HanHsu, et al.
Published: (2019)

<it>O</it><sup><it>6</it></sup>-<it>methylguanine-DNA methyltransferase </it>is downregulated in transformed astrocyte cells: implications for anti-glioma therapies
by: Kaneko Sadao, et al.
Published: (2007-06-01)